Journal of Surgical Education
Volume 64, Issue 1 , Pages 46-50 , January 2007

Marginal Donors in Liver Transplantation: Expanding the Donor Pool

  • Satish N. Nadig, MD

      Affiliations

    • Department of Surgery, Division of Organ Transplantation, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • Charles F. Bratton, MD

      Affiliations

    • Department of Surgery, Division of Transplantation, Medical University of South Carolina, Charleston, South Carolina
    • ,
  • Seth J. Karp, MD

      Affiliations

    • Department of Surgery, Division of Organ Transplantation, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationCorrespondence: Inquiries to Seth J. Karp, MD, Beth Israel Deaconess Medical Center, 110 Francis Street, 7th Floor, Boston, MA 02215

References 

  1. Marsman WA, Wiesner RH, Rodriguez L, et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation. 1999;62:1246–1251
  2. Cheng YF, Chen CL, Lai CY, et al. Assessment of donor fatty livers for liver transplantation. Transplantation. 2001;71:1221–1225
  3. Chavin KD, Fiorini RN, Shafizadeh S, et al. Fatty acid synthase blockade protects steatotic livers from warm ischemia reperfusion injury and transplantation. Am J Trans. 2004;4:1440–1447
  4. Crowley H, Lewis WD, Gordon F, Jenkins R, Khettry U. Staetosis in donor and transplant liver biopsies. Hum Pathol. 2000;31:1209–1213
  5. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Trans. 2003;9:651–663
  6. Nadig SN, Periyasamy B, Shafizadeh SF, et al. Hepatocellular ultrastructure after ischemia/reperfusion injury in human orthotopic liver transplantation. J Gastrointest Surg. 2004;8:695–700
  7. Emond JC, Ascher NL, Busuttil RW. Split liver transplantation in the United States: creation of a national registry and preliminary outcomes. Am J Transplant. 2000;1(suppl 1):260
  8. Couinaud C. Le Foie, Etudes Anatomiques et Chirurgicales. Paris: Masson; 1957;
  9. Bismuth H. Surgical anatomy and anatomical surgery of the liver. World J Surg. 1982;6:3–9
  10. Emond JC, Freeman RB, Renz JF, Yersiz H, Rogiers X, Busuttil RW. Optimizing the use of donated cadaver livers: analysis and policy development to increase the application of split-liver transplantation. Liver Transplant. 2002;8:863–872
  11. Ghobrial RM, Yersiz H, Farmer DG, et al. Predictors of survival after in vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg. 2000;232:312–323
  12. Yersiz H, Renz JF, Farmer DG, Hisatake GM, McDiarmid SV, Busuttil RW. One hundred in situ split-liver transplantations: a single center experience. Ann Surg. 2003;238:496–507
  13. Humar A, Ramcharan T, Sielaff TD, et al. Split liver transplantation for two adult recipients: an initial experience. Am J Trans. 2001;1:366–372
  14. Baccarani U, Adani GL, Risaliti A, et al. Long-term results of in situ split-liver transplantation. Trans Proc. 2005;37:2592–2594
  15. van Der Hoeven JA, Ter Horst GJ, Molema G, et al. Effects of brain death and hemodynamic status on function and immunologic activation of the potential donor liver in the rat. Ann Surg. 2000;232:804–813
  16. Jassem W, Koo DD, Muiesan P, et al. Non-heart-beating versus cadaveric and living-donor livers: differences in inflammatory markers before transplantation. Transplantation. 2003;75:1386–1390
  17. Abt PL, Desai NM, Crawford MD, et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg. 2004;239(1):87–92
  18. Reddy S, Zilvetti M, Brockmann J, McLaren A, Friend P. Liver transplantation from non-heart-beating donors: current status and future prospects. Liver Transplant. 2004;10:1223–1232
  19. Alter MJ. The epidemiology of acute and chronic hepatitis C. Clin Liver Dis. 1997;1:559–568vi-vii
  20. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345(1):41–52
  21. Testa G, Goldstein RM, Netto G, et al. Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. Transplantation. 1998;65:925–929
  22. Buendia MA. Hepatitis B viruses and cancerogenesis. Biomed Pharmacother. 1998;52:34–43
  23. Castells L, Vargas V, Rodriguez-Frias F, et al. Transmission of hepatitis B virus by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Transplant Proc. 1999;31:2464–2465
  24. Uemoto S, Inomata Y, Sannomiya A, et al. Posttransplant hepatitis B infection in liver transplantation with hepatitis B core antibody- positive donors. Transplant Proc. 1998;30:134–135
  25. Saab S, Chang AJ, Comulada S, et al. Outcomes of hepatitis C- and hepatitis B core antibody positive grafts in orthotopic liver transplantation. Liver Transplant. 2003;9:1053–1061
  26. Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc. 1995;27:2893–2894

PII: S0149-7944(06)00131-0

doi: 10.1016/j.cursur.2006.08.001

Journal of Surgical Education
Volume 64, Issue 1 , Pages 46-50 , January 2007

Article Tools

* Image Usage & Resolution